The Zacks Analyst Blog Highlights: Apple, Intel, Advanced Micro Devices and Taiwan Semiconductor

For Immediate Release

Chicago, IL – June 11, 2020 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Apple AAPL, Intel INTC, Advanced Micro Devices AMD and Taiwan Semiconductor TSM.

Here are highlights from Wednesday’s Analyst Blog:

Can Apple Chips Hurt Intel?

A Bloomberg report said that Apple, which has been rumored to be making its own ARM-based chips for Macs for a while now, is finally in a position to announce them at its WWDC annual developers conference a couple of weeks later.

This doesn’t mean, of course, that the chips will be immediately available. Usually, an announcement means that they are likely through with tape out. If all goes well, the chips would be in Apple devices some time next year.

And that’s the crux of the matter. Nothing is expected to happen this year and even if it’s announced, we don’t know for sure that this iteration of the chips will actually find their way into Apple devices.

While ARM designs consume less power, they haven’t been able to beat Intel designs in performance. Not yet, anyway. So it seems extremely unlikely for Apple to go this route.

Unless, and this is a possibility worth considering, Apple is looking to make a lower-end version of its Mac running on ARM chips. Apple could be following the same strategy that it did with the iPhone SE, i.e., making products at multiple price points to target different users. This doesn’t seem to be a far-fetched idea, especially considering that people are likely to be more conservative spenders in a post-COVID world.

There could also be a version using Advanced Micro Devices silicon. AMD is giving some real competition to Intel on the performance front as well, so that’s another possibility Apple could be considering. And since both Apple and AMD use Taiwan Semiconductor as their foundry, it could all be rather smooth.

As far as Intel is concerned, it’s unlikely to get a bloody nose. For one, the company has been defocusing the PC side of its business as it targets the data-centric side. There’s a ton of things going on there where it’s doing rather well. Intel is deeply involved in the expansion of the cloud, AI, the growing interconnectedness of all things (IoT), self-driving cars and ADAS, to name a few. The company’s data-centric business grew 34% year over year to contribute 51% of its revenue in the last quarter.

Since Apple’s announcement won’t bring any immediate changes, Intel will continue to enjoy the benefits of workloads shifting to homes, both on the PC side (as home offices are set up) and on the cloud side (as these offices connect). There’s also a ton of storage, networking and communications tech being deployed there, all of which will strengthen its business in the next few quarters. Also, having made these investments, companies/individuals are unlikely to upgrade/change the very next year. Apple is more likely to score with individual deals at enterprise customers, as has been its strategy in the past.

So this bit of news is a positive for Apple, as it will help the company to lower cost and possibly compete for some lower-end business that will add to its premium business. But it isn’t something Intel investors need to be overly concerned about because Apple is not a very big customer, because it may not sift away entirely and because some share loss to AMD was already in the cards.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339

support@zacks.com                    

https://www.zacks.com

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performancefor information about the performance numbers displayed in this press release.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Intel Corporation (INTC) : Free Stock Analysis Report
 
Apple Inc. (AAPL) : Free Stock Analysis Report
 
Advanced Micro Devices, Inc. (AMD) : Free Stock Analysis Report
 
Taiwan Semiconductor Manufacturing Company Ltd. (TSM) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research